Showing results (71-80 of 115) with videos related to
Sort By:
Pageof 12
Molecular Pain|August 29, 2018
Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic painMalik Bechakra, Mariska D Nieuwenhoff, Joost van Rosmalen, et al.Clinical Pharmacology and Therapeutics|April 20, 2018
Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover TrialMaria O Kovalchuk, Jules A A C Heuberger, Boudewijn T H M Sleutjes, et al.British Journal of Clinical Pharmacology|October 26, 2016
Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedationLenneke Schrier, Rob Zuiker, Frans W H M Merkus, et al.British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.Clinical Therapeutics|February 13, 2017
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple SclerosisGuido van Amerongen, Kawita Kanhai, Anne Catrien Baakman, et al.Journal of Experimental Pharmacology|September 23, 2024
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat StressMarella C E van Ruissen, Sebastiaan J W van Kraaij, Pim Gal, et al.British Journal of Clinical Pharmacology|January 14, 2022
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over studyTitia Q Ruijs, Jules A A C Heuberger, Annika A de Goede, et al.Clinical Pharmacology and Therapeutics|August 21, 2025
Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3-Way Crossover TrialAndriy A Gorbenko, Catherine M K E de Cuba, Annika A de Goede, et al.Diabetes Care|February 17, 2017
Relationships Between Type 2 Diabetes, Neuropathy, and Microvascular Dysfunction: Evidence From Patients With Cryptogenic Axonal PolyneuropathyAnna L Emanuel, Mariska D Nieuwenhoff, Erica S Klaassen, et al.European Journal of Pharmacology|September 26, 2017
Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology studyMarcus P J van Diemen, Cécile L Berends, Naila Akram, et al.Pageof 12